Latest Financial Strategy News

Yugo Metals has appointed Petar Tomašević as its permanent CEO, following his interim leadership that saw significant project milestones. His international experience and regional insight position the company for accelerated growth in Europe's strategic metals sector.

Aurelia Metals has locked in a A$150 million senior secured financing package, strengthening its balance sheet and unlocking restricted cash to support its copper production growth targets.

Botanix Pharmaceuticals has successfully renegotiated its API supply agreement, deferring significant purchases to later years and strengthening its financial position ahead of Sofdra's market rollout.

Sparc Technologies has secured a $680,000 non-dilutive advance on its anticipated FY26 R&D tax refund, strengthening its cash flow as it accelerates commercialisation of its graphene additive ecosparc and green hydrogen ventures.

Native Mineral Resources Holdings Limited has locked in exclusive 12-month mining rights at the Podosky Gold Project in Queensland, backed by promising high-grade drilling results and imminent mining plans.

Deep Yellow Limited has firmly denied recent media speculation about a capital raising, reaffirming its compliance with ASX continuous disclosure rules.

Newmont Corporation’s 2025 Annual Report reveals a robust financial performance driven by higher gold prices and portfolio optimisation, alongside significant progress in key development projects and sustainability initiatives.

Ramelius Resources has delivered its first ore from the Never Never deposit to the Mt Magnet plant, marking a key step in its growth strategy, while also closing out its FY27 gold hedge book to increase exposure to rising gold prices.

Austral Resources has executed binding agreements to acquire the Lady Loretta mine from Glencore and plans to repay its Rocklands Facility debt, positioning itself as a debt-free copper producer with enhanced financial flexibility.

Native Mineral Resources has made early repayments totalling nearly $2 million on its Collins St finance facility, reducing its debt well ahead of schedule. This move underscores the company's robust cash flow and strategic focus on its Charters Towers gold projects.

Apiam Animal Health has secured court approval for its corporate scheme, paving the way for a fully franked special dividend payment next month.

Genetic Signatures has appointed Maria Halasz as its new CEO, bringing over two decades of leadership in life sciences and capital markets to steer the company’s global expansion.